Details

NameSymbolSector
BIOGEN PHARMACHEM INDUSTRIES LIMITEDBIOGENOther Financial Services
Open
0.49
High
0.51
Low
0.46
Close
0.47
Volume
15391254
Exchange
bse
Time
28-Apr-2026

Outlook

Score:

0

Rating:

RISKY

Candlestick Pattern

CandlepatternofBiogenPharmachemIndustriesis
None
EstimatedStoplossofBiogenPharmachemIndustriesis
0.51
BiogenPharmachemIndustrieshasa
Bearishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofBiogenPharmachemIndustriesis
Unpredictableℹ
.

Trend

BiogenPharmachemIndustriesisin
Sideways trendℹ
.
PriceofBiogenPharmachemIndustriesis
Downℹ
by

22.95

%.
Target
Buy@

0.45

Sell@

0.75

Current@

0.47

Volume

ThetradesofBiogenPharmachemIndustrieshavebeenin
Immenseℹ
volume.
ThevolumetradesforBiogenPharmachemIndustriesare
Bearishℹ
with
Strong Sellersℹ
ThetradevolumeofBiogenPharmachemIndustriesis

Up

by

312.55

%

Valuation

ThecurrentmarketpriceofBiogenPharmachemIndustriesis
Fairℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth92crandtotalassetsworth92cr,thebalancesheetofBiogenPharmachemIndustriesis:
Balancedℹ
.
Cashflow
BiogenPharmachemIndustrieshas
Sufficientℹ
cashflowbecausethereis

Surplus

of

₹ 2cr

.Itis
Upℹ
by

0

%.
1.47% i.e. ₹ 1cr spent in operatingℹ
47.06% i.e. ₹ 32cr spent in investingℹ
51.47% i.e. ₹ 35cr earned in financingℹ
0% in otherℹ
BiogenPharmachemIndustrieshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Downℹ
by

0

%.
33.33% i.e. ₹ 1cr earned in operatingℹ
66.67% i.e. ₹ 2cr spent in investingℹ
0% in financingℹ
0% in otherℹ
Income
TheincomeofBiogenPharmachemIndustriesis

₹ 0cr

and

Loss

is:

₹ 0cr

BiogenPharmachemIndustriesLossesincreasedby:

100

%andIncomeisDownby:

100

%
TheincomeofBiogenPharmachemIndustriesis

₹ 1cr

and

Profit

is:

₹ 1cr

BiogenPharmachemIndustriesProfitisupby:

0

%andIncomeisUpby:

0

%
TheincomeofBiogenPharmachemIndustriesis

₹ 1cr

and

Profit

is:

₹ 1cr

BiogenPharmachemIndustriesProfitisupby:

100

%andIncomeisUpby:

100

%
By using this site you agree to the use of cookies to deliver a better site experience.